Jeffrey L. Masten
2013
In 2013, Jeffrey L. Masten earned a total compensation of $684.9K as Former Vice President, Quality at Peregrine Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $97,256 |
---|---|
Option Awards | $193,410 |
Salary | $296,181 |
Other | $98,045 |
Total | $684,892 |
Masten received $296.2K in salary, accounting for 43% of the total pay in 2013.
Masten also received $97.3K in non-equity incentive plan, $193.4K in option awards and $98K in other compensation.
Rankings
In 2013, Jeffrey L. Masten's compensation ranked 8,225th out of 12,286 executives tracked by ExecPay. In other words, Masten earned more than 33.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,225 out of 12,286 | 33rd |
Division Manufacturing | 2,980 out of 4,612 | 35th |
Major group Chemicals And Allied Products | 931 out of 1,462 | 36th |
Industry group Drugs | 706 out of 1,156 | 39th |
Industry Pharmaceutical Preparations | 558 out of 890 | 37th |
Source: SEC filing on August 28, 2014.
Masten's colleagues
We found five more compensation records of executives who worked with Jeffrey L. Masten at Peregrine Pharmaceuticals in 2013.
2013
Steven King
Peregrine Pharmaceuticals
Chief Executive Officer
2013
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2013
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
2013
Shelley Fussey
Peregrine Pharmaceuticals
Vice President, Intellectual Property
2013
Joseph Shan
Peregrine Pharmaceuticals